Hypothyroidism in metabolic syndrome
Sunil Kumar Kota1, Lalit Kumar Meher, Svs Krishna
1Department of Endocrinology, Medwin hospital, Hyderabad, India.
Indian Journal of Endocrinology and Metabolism
|April 9, 2013
Summary
Metabolic syndrome is linked to higher thyroid-stimulating hormone (TSH) levels, indicating a potential association with hypothyroidism. This study investigated thyroid function in metabolic syndrome patients, revealing significant differences in key metabolic and thyroid markers compared to controls.
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Disease Research
Background:
- Metabolic syndrome (MetS) and hypothyroidism are recognized risk factors for atherogenic cardiovascular disease.
- Shared pathogenic mechanisms, particularly insulin resistance, link MetS and cardiovascular disease.
- Thyroid dysfunction, specifically hypothyroidism, may play a role in the development of MetS.
Purpose of the Study:
- To evaluate thyroid function in patients diagnosed with metabolic syndrome.
- To investigate the potential association between hypothyroidism and the presence of metabolic syndrome.
- To compare thyroid function parameters between individuals with and without metabolic syndrome.
Main Methods:
- A cross-sectional study included 100 patients meeting NCEP-ATP III criteria for MetS and 50 controls.
- Exclusion criteria included liver/renal disorders, heart failure, pregnancy, and medications affecting thyroid or lipid levels.
- Anthropometry, vital signs, lipid profiles, thyroid function tests (including TSH), and routine labs were performed. Statistical analysis used t-tests, chi-square, and regression models.
Main Results:
- The MetS group exhibited significantly higher body mass index, waist circumference, blood pressure, fasting blood sugar, triglycerides, total cholesterol, LDL-C, and TSH levels compared to controls.
- High-density lipoprotein cholesterol (HDL-C) levels were significantly lower in the MetS group.
- Age and sex distributions were similar between the study and control groups.
Conclusions:
- Patients with metabolic syndrome demonstrate significantly altered lipid profiles and elevated TSH levels, suggesting a link with hypothyroidism.
- The findings support the investigation of thyroid function in individuals with metabolic syndrome.
- Further research is warranted to elucidate the causal relationship and clinical implications of hypothyroidism in metabolic syndrome.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.